{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06257875",
            "orgStudyIdInfo": {
                "id": "M23-703"
            },
            "secondaryIdInfos": [
                {
                    "id": "2023-505678-14-00",
                    "type": "OTHER",
                    "domain": "EU CT"
                }
            ],
            "organization": {
                "fullName": "AbbVie",
                "class": "INDUSTRY"
            },
            "briefTitle": "A Study to Assess Adverse Events and Change in Disease Activity From Intravenous (IV) and Subcutaneous (SC) Lutikizumab in Adult Participants With Active Ulcerative Colitis",
            "officialTitle": "A Multicenter, Randomized Study to Evaluate the Safety and Efficacy of Lutikizumab for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis",
            "therapeuticArea": [
                "Gastroenterology"
            ],
            "study": "a-study-to-assess-adverse-events-and-change-in-disease-activity-from-intravenous-iv-and-subcutaneous-sc-lutikizumab-in-adult-participants-with-active-ulcerative-colitis"
        },
        "statusModule": {
            "statusVerifiedDate": "2024-07",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2024-03-23",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2027-04-23",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2027-04-23",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-10-02",
            "studyFirstSubmitQcDate": "2024-02-06",
            "studyFirstPostDateStruct": {
                "date": "2024-02-14",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2024-07-25",
            "lastUpdatePostDateStruct": {
                "date": "2024-07-29",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "SPONSOR"
            },
            "leadSponsor": {
                "name": "AbbVie",
                "class": "INDUSTRY"
            }
        },
        "oversightModule": {
            "oversightHasDmc": true,
            "isFdaRegulatedDrug": true,
            "isFdaRegulatedDevice": false,
            "isUsExport": false
        },
        "descriptionModule": {
            "briefSummary": "Ulcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). The purpose of this study is to assess how safe and effective lutikizumab is in adult subjects with UC and how lutikizumab compares to adalimumab in the treatment of UC. Adverse events and changes in disease activity will be assessed.\n\nLutikizumab is an investigational product being developed for the treatment of UC. Participants are placed in groups called treatment arms. Each group receives a different treatment. In the Induction Period, participants will be randomized into 1 of 3 arms receiving lutikizumab Dose 1, lutikizumab Dose 2, or adalimumab. In the Maintenance Period, participants who responded to lutikizumab will be randomized into 1 of 2 arms of lutikizumab maintenance and participants who responded to adalimumab will continue to receive adalimumab. All participants who did not achieve clinical response per modified Mayo Score at the end of the Induction period will receive open label lutikizumab. Around 200 adult participants with UC will be enrolled at approximately 280 sites worldwide.\n\nIn the Induction Period, participants will be randomized to receive intravenous (IV) and subcutaneous (SC) lutikizumab or SC adalimumab for 12 weeks. At the 12 week mark, participants who are on lutikizumab who have responded to treatment will be re-randomized to receive SC lutikizumab at different intervals until Week 52. Participants who are on adalimumab who are responding to treatment will continue to receive adalimumab until Week 52. Participants who do not respond to treatment will receive open-label SC lutikizumab until Week 52.\n\nThere may be higher treatment burden for participants in this trial compared to their standard of care. Participants will attend regular visits during the study at a hospital or clinic. The effect of the treatment will be checked by medical assessments, blood tests, checking for side effects and completing questionnaires."
        },
        "conditionsModule": {
            "conditions": [
                "Ulcerative Colitis"
            ],
            "keywords": [
                "Ulcerative Colitis",
                "Lutikizumab",
                "Adalimumab"
            ]
        },
        "designModule": {
            "studyType": "INTERVENTIONAL",
            "phases": [
                "PHASE2"
            ],
            "designInfo": {
                "allocation": "RANDOMIZED",
                "interventionModel": "SEQUENTIAL",
                "primaryPurpose": "TREATMENT",
                "maskingInfo": {
                    "masking": "QUADRUPLE",
                    "whoMasked": [
                        "PARTICIPANT",
                        "CARE_PROVIDER",
                        "INVESTIGATOR",
                        "OUTCOMES_ASSESSOR"
                    ]
                }
            },
            "enrollmentInfo": {
                "count": 200,
                "type": "ESTIMATED"
            }
        },
        "armsInterventionsModule": {
            "armGroups": [
                {
                    "label": "Induction Group 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive Dose 1 of IV lutikizumab at Baseline followed by SC lutikizumab throughout induction. Adalimumab placebo will be utilized to maintain the blind.",
                    "interventionNames": [
                        "Drug: Adalimumab Matching Placebo",
                        "Drug: Lutikizumab"
                    ]
                },
                {
                    "label": "Induction Group 2",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive Dose 2 of IV lutikizumab at Baseline followed by SC lutikizumab throughout induction. Lutikizumab placebo and adalimumab placebo will be utilized to maintain the blind.",
                    "interventionNames": [
                        "Drug: Adalimumab Matching Placebo",
                        "Drug: Lutikizumab"
                    ]
                },
                {
                    "label": "Induction Group 3",
                    "type": "EXPERIMENTAL",
                    "description": "Participants will receive adalimumab per label throughout induction. Lutikizumab placebo will be utilized to maintain the blind.",
                    "interventionNames": [
                        "Drug: Lutikizumab Matching Placebo",
                        "Drug: Adalimumab"
                    ]
                },
                {
                    "label": "Maintenance Group 1",
                    "type": "EXPERIMENTAL",
                    "description": "Participants who responded to lutikizumab induction group 1 or 2 will be re-randomized. Participants in this group will receive SC lutikizumab throughout the maintenance period. Adalimumab placebo will be utilized to maintain the blind.",
                    "interventionNames": [
                        "Drug: Adalimumab Matching Placebo",
                        "Drug: Lutikizumab"
                    ]
                },
                {
                    "label": "Maintenance Group 2",
                    "type": "EXPERIMENTAL",
                    "description": "Participants who responded to lutikizumab induction group 1 or 2 will be re-randomized. Participants in this group will receive SC lutikizumab throughout the maintenance period. Lutikizumab placebo and adalimumab placebo will be utilized to maintain the blind.",
                    "interventionNames": [
                        "Drug: Lutikizumab Matching Placebo",
                        "Drug: Adalimumab Matching Placebo",
                        "Drug: Lutikizumab"
                    ]
                },
                {
                    "label": "Maintenance Adalimumab",
                    "type": "EXPERIMENTAL",
                    "description": "Participants who respond to adalimumab induction group 3 will continue to receive adalimumab per label in the maintenance period. Lutikizumab placebo will be utilized to maintain the blind.",
                    "interventionNames": [
                        "Drug: Lutikizumab Matching Placebo",
                        "Drug: Adalimumab"
                    ]
                },
                {
                    "label": "Maintenance Non-Responders",
                    "type": "EXPERIMENTAL",
                    "description": "Participants who do not respond to study drug at the end of induction period will receive open label SC lutikizumab in the maintenance period.",
                    "interventionNames": [
                        "Drug: Lutikizumab"
                    ]
                }
            ],
            "interventions": [
                {
                    "type": "DRUG",
                    "name": "Lutikizumab Matching Placebo",
                    "description": "SC Injection",
                    "armGroupLabels": [
                        "Induction Group 3",
                        "Maintenance Adalimumab",
                        "Maintenance Group 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lutikizumab Matching Placebo",
                    "description": "IV Infusion",
                    "armGroupLabels": [
                        "Induction Group 3"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Adalimumab Matching Placebo",
                    "description": "SC Injection",
                    "armGroupLabels": [
                        "Induction Group 1",
                        "Induction Group 2",
                        "Maintenance Group 1",
                        "Maintenance Group 2"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lutikizumab",
                    "description": "Subcutaneous (SC) Injection",
                    "armGroupLabels": [
                        "Induction Group 1",
                        "Induction Group 2",
                        "Maintenance Group 1",
                        "Maintenance Group 2",
                        "Maintenance Non-Responders"
                    ],
                    "otherNames": [
                        "ABT-981"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Lutikizumab",
                    "description": "Intravenous (IV) Infusion",
                    "armGroupLabels": [
                        "Induction Group 1",
                        "Induction Group 2"
                    ],
                    "otherNames": [
                        "ABT-981"
                    ]
                },
                {
                    "type": "DRUG",
                    "name": "Adalimumab",
                    "description": "SC Injection",
                    "armGroupLabels": [
                        "Induction Group 3",
                        "Maintenance Adalimumab"
                    ],
                    "otherNames": [
                        "Humira"
                    ]
                }
            ]
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Percentage of Participants who Achieve Endoscopic Improvement",
                    "description": "Endoscopic Improvement is defined as Mayo Endoscopic Subscore (ESS) of 0 or 1. Endoscopies were assessed by a blinded central reader and scored according to the following scale: 0 = Normal appearance of mucosa; 1 = Mild disease (erythema, decreased vascular pattern); 2 = Moderate disease (marked erythema, lack of vascular pattern, any friability, erosions); 3 = Severe disease (spontaneous bleeding, ulceration).",
                    "timeFrame": "Week 12"
                },
                {
                    "measure": "Number of Participants with Adverse Events (AEs)",
                    "description": "An AE is defined as any untoward medical occurrence in a patient or clinical investigation participant administered a pharmaceutical product which does not necessarily have a causal relationship with this treatment.",
                    "timeFrame": "Up to approximately Week 64"
                }
            ],
            "secondaryOutcomes": [
                {
                    "measure": "Percentage of Participants who Achieve Clinical Remission Per Modified Mayo Score (mMS)",
                    "description": "Clinical remission on the mMS is defined as Endoscopy subscore = 0 or 1, AND Rectal bleeding subscore = 0, AND Stool frequency subscore \\<= 1, AND not greater than baseline. The mMS is a composite score of UC disease activity based on the following 3 subscores: SFS, scored from 0 (normal number of stools) to 3 (5 or more stools more than normal); RBS, scored from 0 (no blood seen) to 3 (blood alone passed); ESS, scored from 0 (normal appearance of mucosa) to 3 (severe disease \\[spontaneous bleeding, ulceration\\]). The overall mMS ranges from 0 to 9 with higher scores representing more severe disease. The number of responders is calculated based on the total number of participants and estimated response rate, rounding to a nearest whole integer.",
                    "timeFrame": "Week 12"
                },
                {
                    "measure": "Percentage of Participants who Achieve Clinical Response Per mMS",
                    "description": "Clinical response per mMS is defined as decrease from baseline \\>=2 points and \\>=30%, PLUS a decrease in RBS \\>= 1 or an absolute RBS \\<=1. The mMS is a composite score of UC disease activity based on the following 3 subscores: SFS, scored from 0 (normal number of stools) to 3 (5 or more stools more than normal); RBS, scored from 0 (no blood seen) to 3 (blood alone passed); ESS, scored from 0 (normal appearance of mucosa) to 3 (severe disease \\[spontaneous bleeding, ulceration\\]). The overall mMS ranges from 0 to 9 with higher scores representing more severe disease. The number of responders is calculated based on the total number of participants and estimated response rate, rounding to a nearest whole integer.",
                    "timeFrame": "Week 12"
                },
                {
                    "measure": "Percentage of Participants who Achieve Endoscopic Remission",
                    "description": "Endoscopic remission is defined as Mayo Endoscopic Subscore (ESS) of 0. Endoscopies were assessed by a blinded central reader and scored according to the following scale: 0 = Normal appearance of mucosa; 1 = Mild disease (erythema, decreased vascular pattern); 2 = Moderate disease (marked erythema, lack of vascular pattern, any friability, erosions); 3 = Severe disease (spontaneous bleeding, ulceration).",
                    "timeFrame": "Week 12"
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* Participant has had a diagnosis of Ulcerative Colitis (UC) for at least 90 days prior to Baseline. Appropriate documentation of biopsy results consistent with the diagnosis of UC in the assessment of the investigator, must be available.\n* Active UC with a Modified Mayo Score (mMS) of 5 to 9 points and Mayo Endoscopic Subscore (ESS) of 2 to 3 (confirmed by central review).\n* Demonstrated inadequate response to, loss of response to, or intolerance to at least one of the following: oral aminosalicylates, corticosteroids, immunomodulators, and/or advanced therapies.\n\nExclusion Criteria:\n\n* Current diagnosis of Crohn's Disease (CD) or inflammatory bowel disease-unclassified.\n* Extent of inflammatory disease limited to the rectum as assessed by screening endoscopy.\n* Prior exposure to adalimumab (including biosimilars). Note: Subject may be enrolled if he/she has been exposed to other advanced therapies, including anti-TNFs other than adalimumab.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "18 Years",
            "stdAges": [
                "ADULT",
                "OLDER_ADULT"
            ]
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "ABBVIE CALL CENTER",
                    "role": "CONTACT",
                    "phone": "844-663-3742",
                    "email": "abbvieclinicaltrials@abbvie.com"
                }
            ],
            "overallOfficials": [
                {
                    "name": "ABBVIE INC.",
                    "affiliation": "AbbVie",
                    "role": "STUDY_DIRECTOR"
                }
            ],
            "locations": [
                {
                    "facility": "Gastro SB /ID# 258331",
                    "status": "RECRUITING",
                    "city": "Chula Vista",
                    "state": "California",
                    "zip": "91910-5619",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.64005,
                        "lon": -117.0842
                    }
                },
                {
                    "facility": "Newport Huntington Medical Group /ID# 258371",
                    "status": "RECRUITING",
                    "city": "Huntington Beach",
                    "state": "California",
                    "zip": "92648-5994",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.6603,
                        "lon": -117.99923
                    }
                },
                {
                    "facility": "Om Research LLC /ID# 261383",
                    "status": "RECRUITING",
                    "city": "Lancaster",
                    "state": "California",
                    "zip": "93534",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 34.69804,
                        "lon": -118.13674
                    }
                },
                {
                    "facility": "Research Associates of South Florida, LLC /ID# 259813",
                    "status": "RECRUITING",
                    "city": "Coral Gables",
                    "state": "Florida",
                    "zip": "33134-2442",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.72149,
                        "lon": -80.26838
                    }
                },
                {
                    "facility": "Auzmer Research /ID# 260940",
                    "status": "RECRUITING",
                    "city": "Lakeland",
                    "state": "Florida",
                    "zip": "33813-4924",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "863-450-2580"
                        }
                    ],
                    "geoPoint": {
                        "lat": 28.03947,
                        "lon": -81.9498
                    }
                },
                {
                    "facility": "Atlantic Medical Research /ID# 258507",
                    "status": "RECRUITING",
                    "city": "Margate",
                    "state": "Florida",
                    "zip": "33063-5737",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 26.24453,
                        "lon": -80.20644
                    }
                },
                {
                    "facility": "Homestead Associates in Research /ID# 260392",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33032",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "JD Medical Group, LLC /ID# 261235",
                    "status": "RECRUITING",
                    "city": "Miami",
                    "state": "Florida",
                    "zip": "33176-2302",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 25.77427,
                        "lon": -80.19366
                    }
                },
                {
                    "facility": "Gastroenterology Group Naples /ID# 258346",
                    "status": "RECRUITING",
                    "city": "Naples",
                    "state": "Florida",
                    "zip": "34102",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "239-649-1336"
                        }
                    ],
                    "geoPoint": {
                        "lat": 26.14234,
                        "lon": -81.79596
                    }
                },
                {
                    "facility": "Atlanta Ctr. for Gastro /ID# 259275",
                    "status": "RECRUITING",
                    "city": "Decatur",
                    "state": "Georgia",
                    "zip": "30033",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 33.77483,
                        "lon": -84.29631
                    }
                },
                {
                    "facility": "Gastroenterology Associates of Central Georgia, LLC /ID# 258359",
                    "status": "RECRUITING",
                    "city": "Macon",
                    "state": "Georgia",
                    "zip": "31201",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "478-464-2600 ext.115"
                        }
                    ],
                    "geoPoint": {
                        "lat": 32.84069,
                        "lon": -83.6324
                    }
                },
                {
                    "facility": "Gastroenterology Consultants, P.C /ID# 258352",
                    "status": "RECRUITING",
                    "city": "Roswell",
                    "state": "Georgia",
                    "zip": "30076-4913",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "404-596-4480"
                        }
                    ],
                    "geoPoint": {
                        "lat": 34.02316,
                        "lon": -84.36159
                    }
                },
                {
                    "facility": "Louisiana Research Center, LLC /ID# 258330",
                    "status": "RECRUITING",
                    "city": "Shreveport",
                    "state": "Louisiana",
                    "zip": "71105-6800",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.52515,
                        "lon": -93.75018
                    }
                },
                {
                    "facility": "Clin Res Inst of Michigan, LLC /ID# 258386",
                    "status": "RECRUITING",
                    "city": "Chesterfield",
                    "state": "Michigan",
                    "zip": "48047",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.66281,
                        "lon": -82.84242
                    }
                },
                {
                    "facility": "Clin Res Inst of Michigan, LLC /ID# 259267",
                    "status": "RECRUITING",
                    "city": "Chesterfield",
                    "state": "Michigan",
                    "zip": "48047",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "586-598-3329"
                        }
                    ],
                    "geoPoint": {
                        "lat": 42.66281,
                        "lon": -82.84242
                    }
                },
                {
                    "facility": "Gastroenterology Associates of Western Michigan, PLC d.b.a. West Michigan Clinic /ID# 258493",
                    "status": "RECRUITING",
                    "city": "Wyoming",
                    "state": "Michigan",
                    "zip": "49519",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 42.91336,
                        "lon": -85.70531
                    }
                },
                {
                    "facility": "DJL Clinical Research, PLLC /ID# 259465",
                    "status": "RECRUITING",
                    "city": "Charlotte",
                    "state": "North Carolina",
                    "zip": "28211",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.22709,
                        "lon": -80.84313
                    }
                },
                {
                    "facility": "Plains Clinical Research Center, LLC /ID# 258502",
                    "status": "RECRUITING",
                    "city": "Fargo",
                    "state": "North Dakota",
                    "zip": "58104-5925",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 46.87719,
                        "lon": -96.7898
                    }
                },
                {
                    "facility": "Digestive Disease Specialists /ID# 258499",
                    "status": "RECRUITING",
                    "city": "Oklahoma City",
                    "state": "Oklahoma",
                    "zip": "73112",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 35.46756,
                        "lon": -97.51643
                    }
                },
                {
                    "facility": "BioStar Clinical Research Group - Houston - Katy Freeway /ID# 261164",
                    "status": "RECRUITING",
                    "city": "Houston",
                    "state": "Texas",
                    "zip": "77084",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Site Coordinator",
                            "role": "CONTACT",
                            "phone": "281-975-2895"
                        }
                    ],
                    "geoPoint": {
                        "lat": 29.76328,
                        "lon": -95.36327
                    }
                },
                {
                    "facility": "Clinical Associates in Research Therapeutics of America, LLC /ID# 258403",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78212",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Southern Star Research Institute, LLC /ID# 258347",
                    "status": "RECRUITING",
                    "city": "San Antonio",
                    "state": "Texas",
                    "zip": "78229-5390",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 29.42412,
                        "lon": -98.49363
                    }
                },
                {
                    "facility": "Tyler Research Institute, LLC /ID# 258383",
                    "status": "RECRUITING",
                    "city": "Tyler",
                    "state": "Texas",
                    "zip": "75701",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 32.35126,
                        "lon": -95.30106
                    }
                },
                {
                    "facility": "Wisconsin Center for Advanced Research /ID# 258949",
                    "status": "RECRUITING",
                    "city": "Milwaukee",
                    "state": "Wisconsin",
                    "zip": "53215",
                    "country": "United States",
                    "geoPoint": {
                        "lat": 43.0389,
                        "lon": -87.90647
                    }
                },
                {
                    "facility": "Toronto Digestive Disease Associates, Inc. /ID# 260460",
                    "status": "RECRUITING",
                    "city": "Vaughan",
                    "state": "Ontario",
                    "zip": "L4L 4Y7",
                    "country": "Canada",
                    "geoPoint": {
                        "lat": 43.8361,
                        "lon": -79.49827
                    }
                },
                {
                    "facility": "Soroka University Medical Center /ID# 258530",
                    "status": "RECRUITING",
                    "city": "Be'er Sheva",
                    "state": "HaDarom",
                    "zip": "8410101",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.25181,
                        "lon": 34.7913
                    }
                },
                {
                    "facility": "Yitzhak Shamir Medical Center /ID# 258533",
                    "status": "RECRUITING",
                    "city": "Zerifin",
                    "state": "HaMerkaz",
                    "zip": "70300",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.95857,
                        "lon": 4.83723
                    }
                },
                {
                    "facility": "Tel Aviv Sourasky Medical Center /ID# 258528",
                    "status": "RECRUITING",
                    "city": "Tel Aviv",
                    "state": "Tel-Aviv",
                    "zip": "6423906",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.08088,
                        "lon": 34.78057
                    }
                },
                {
                    "facility": "Shaare Zedek Medical Center /ID# 258529",
                    "status": "RECRUITING",
                    "city": "Jerusalem",
                    "state": "Yerushalayim",
                    "zip": "91031",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 31.76904,
                        "lon": 35.21633
                    }
                },
                {
                    "facility": "Rabin Medical Center /ID# 258531",
                    "status": "RECRUITING",
                    "city": "Haifa",
                    "zip": "4941492",
                    "country": "Israel",
                    "geoPoint": {
                        "lat": 32.81841,
                        "lon": 34.9885
                    }
                },
                {
                    "facility": "Gamagori City Hospital /ID# 260682",
                    "status": "RECRUITING",
                    "city": "Gamagori-shi",
                    "state": "Aichi",
                    "zip": "443-8501",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.83333,
                        "lon": 137.23333
                    }
                },
                {
                    "facility": "Tsujinaka Hospital Kashiwanoha /ID# 258548",
                    "status": "RECRUITING",
                    "city": "Kashiwa-shi",
                    "state": "Chiba",
                    "zip": "277-0871",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.86224,
                        "lon": 139.97732
                    }
                },
                {
                    "facility": "Gifu University Hospital /ID# 259572",
                    "status": "RECRUITING",
                    "city": "Gifu-shi",
                    "state": "Gifu",
                    "zip": "501-1194",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.42291,
                        "lon": 136.76039
                    }
                },
                {
                    "facility": "Ogaki Municipal Hospital /ID# 259905",
                    "status": "RECRUITING",
                    "city": "Ogaki-shi",
                    "state": "Gifu",
                    "zip": "503-8502",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 35.35,
                        "lon": 136.61667
                    }
                },
                {
                    "facility": "Aoyama Clinic /ID# 259587",
                    "status": "RECRUITING",
                    "city": "Kobe-shi",
                    "state": "Hyogo",
                    "zip": "650-0015",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.6913,
                        "lon": 135.183
                    }
                },
                {
                    "facility": "Sameshima Hospital /ID# 259589",
                    "status": "RECRUITING",
                    "city": "Kagoshima-shi",
                    "state": "Kagoshima",
                    "zip": "892-0846",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 31.56667,
                        "lon": 130.55
                    }
                },
                {
                    "facility": "Kagoshima IBD Gastroenterology Clinic /ID# 259603",
                    "status": "RECRUITING",
                    "city": "Kagoshima-shi",
                    "state": "Kagoshima",
                    "zip": "8920804",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 31.56667,
                        "lon": 130.55
                    }
                },
                {
                    "facility": "Sai Gastroenterology and Proctology Clinic /ID# 260832",
                    "status": "RECRUITING",
                    "city": "Fujidera-shi",
                    "state": "Osaka",
                    "zip": "583-0027",
                    "country": "Japan"
                },
                {
                    "facility": "Kinshukai Infusion Clinic /ID# 259588",
                    "status": "RECRUITING",
                    "city": "Osaka-shi",
                    "state": "Osaka",
                    "zip": "530-0011",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 34.69374,
                        "lon": 135.50218
                    }
                },
                {
                    "facility": "Saga University Hospital /ID# 259625",
                    "status": "RECRUITING",
                    "city": "Saga-shi",
                    "state": "Saga",
                    "zip": "849-8501",
                    "country": "Japan",
                    "geoPoint": {
                        "lat": 33.23333,
                        "lon": 130.3
                    }
                },
                {
                    "facility": "Waikato Hospital /ID# 258607",
                    "status": "RECRUITING",
                    "city": "Hamilton",
                    "state": "Waikato",
                    "zip": "3240",
                    "country": "New Zealand",
                    "geoPoint": {
                        "lat": -37.78333,
                        "lon": 175.28333
                    }
                },
                {
                    "facility": "Inselspital, Universitaetsspital Bern /ID# 260106",
                    "status": "RECRUITING",
                    "city": "Bern",
                    "zip": "3010",
                    "country": "Switzerland",
                    "geoPoint": {
                        "lat": 46.94809,
                        "lon": 7.44744
                    }
                },
                {
                    "facility": "National Taiwan University Hospital /ID# 258476",
                    "status": "RECRUITING",
                    "city": "Taipei City",
                    "state": "Taipei",
                    "zip": "100",
                    "country": "Taiwan",
                    "geoPoint": {
                        "lat": 25.04776,
                        "lon": 121.53185
                    }
                }
            ]
        },
        "referencesModule": {
            "seeAlsoLinks": [
                {
                    "label": "Related Info",
                    "url": "https://www.abbvieclinicaltrials.com/study/?id=M23-703"
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "YES",
            "description": "AbbVie is committed to responsible clinical trial data sharing. This includes access to anonymized, individual and trial-level data (analysis data sets), as well as other information.",
            "infoTypes": [
                "STUDY_PROTOCOL",
                "SAP",
                "CSR"
            ],
            "timeFrame": "For details on when studies are available for sharing visit https://vivli.org/ourmember/abbvie/",
            "accessCriteria": "To learn more about the process, or to submit a request, visit the following link https://www.abbvieclinicaltrials.com/hcp/data-sharing/",
            "url": "https://vivli.org/ourmember/abbvie/"
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000003092",
                    "term": "Colitis"
                },
                {
                    "id": "D000003093",
                    "term": "Colitis, Ulcerative"
                },
                {
                    "id": "D000014456",
                    "term": "Ulcer"
                }
            ],
            "ancestors": [
                {
                    "id": "D000005759",
                    "term": "Gastroenteritis"
                },
                {
                    "id": "D000005767",
                    "term": "Gastrointestinal Diseases"
                },
                {
                    "id": "D000004066",
                    "term": "Digestive System Diseases"
                },
                {
                    "id": "D000003108",
                    "term": "Colonic Diseases"
                },
                {
                    "id": "D000007410",
                    "term": "Intestinal Diseases"
                },
                {
                    "id": "D000010335",
                    "term": "Pathologic Processes"
                },
                {
                    "id": "D000015212",
                    "term": "Inflammatory Bowel Diseases"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M17206",
                    "name": "Ulcer",
                    "asFound": "Ulcerative",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6320",
                    "name": "Colitis",
                    "asFound": "Colitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M6321",
                    "name": "Colitis, Ulcerative",
                    "asFound": "Ulcerative Colitis",
                    "relevance": "HIGH"
                },
                {
                    "id": "M8875",
                    "name": "Gastroenteritis",
                    "relevance": "LOW"
                },
                {
                    "id": "M7255",
                    "name": "Digestive System Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M8883",
                    "name": "Gastrointestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M6336",
                    "name": "Colonic Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M10444",
                    "name": "Intestinal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M17917",
                    "name": "Inflammatory Bowel Diseases",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC06",
                    "name": "Digestive System Diseases"
                }
            ]
        },
        "interventionBrowseModule": {
            "meshes": [
                {
                    "id": "D000068879",
                    "term": "Adalimumab"
                }
            ],
            "ancestors": [
                {
                    "id": "D000079424",
                    "term": "Tumor Necrosis Factor Inhibitors"
                },
                {
                    "id": "D000000893",
                    "term": "Anti-Inflammatory Agents"
                },
                {
                    "id": "D000018501",
                    "term": "Antirheumatic Agents"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M326",
                    "name": "Adalimumab",
                    "asFound": "Of 5",
                    "relevance": "HIGH"
                },
                {
                    "id": "M4854",
                    "name": "Benzocaine",
                    "relevance": "LOW"
                },
                {
                    "id": "M2052",
                    "name": "Tumor Necrosis Factor Inhibitors",
                    "relevance": "LOW"
                },
                {
                    "id": "M4217",
                    "name": "Anti-Inflammatory Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "M20604",
                    "name": "Antirheumatic Agents",
                    "relevance": "LOW"
                },
                {
                    "id": "T433",
                    "name": "Tannic Acid",
                    "relevance": "LOW"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "Infl",
                    "name": "Anti-Inflammatory Agents"
                },
                {
                    "abbrev": "ARhu",
                    "name": "Antirheumatic Agents"
                },
                {
                    "abbrev": "All",
                    "name": "All Drugs and Chemicals"
                },
                {
                    "abbrev": "CNSDep",
                    "name": "Central Nervous System Depressants"
                },
                {
                    "abbrev": "Ot",
                    "name": "Other Dietary Supplements"
                }
            ]
        }
    },
    "hasResults": false
}